Siga Technologies

SIGANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$218.758 M

$3.05 -2.24%

Close of 7 Aug 2026

Revenue

$94.6M

#2536 by revenue

Earnings

$23.3M

#1826 by earnings

Shares outstanding

71,849,716

Latest filing cover page

P/E ratio

9.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#259Pyxis OncologyPYXS$236.3M
#260Keros TherapeuticsKROS$221.1M
#261Siga TechnologiesSIGA$218.8M
#262AN2 TherapeuticsANTX$213.6M
#263Atrium TherapeuticsRNA$211.1M

Where these numbers come from

Share counts and financials for Siga Technologies are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.